Haass, N. K., Nassif, N., & McGowan, E. M. (2015). Switching the Sphingolipid Rheostat in the Treatment of Diabetes and Cancer Comorbidity from a Problem to an Advantage. Biomed Res Int.
Citação norma ChicagoHaass, Nikolas K., Najah Nassif, and Eileen M. McGowan. "Switching the Sphingolipid Rheostat in the Treatment of Diabetes and Cancer Comorbidity From a Problem to an Advantage." Biomed Res Int 2015.
Citação norma MLAHaass, Nikolas K., Najah Nassif, and Eileen M. McGowan. "Switching the Sphingolipid Rheostat in the Treatment of Diabetes and Cancer Comorbidity From a Problem to an Advantage." Biomed Res Int 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.